Acrivon Therapeutics, Inc. logo

Acrivon Therapeutics, Inc. Income Statement

Revenue, expenses, and profitability over time
Market Cap$51.5M

No metrics found for this filter.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.